Additionally, we identified a novel mechanism by which NANOG increases the metastatic potential of ovarian cancer cells by regulating the AMPK/mTOR pathway, which might foster new therapeutic strategies for the treatment of ovarian cancer. The gene discussed is MTOR; the disease is ovarian carcinoma.